Search

A new policy brief by King’s College London sets out ideas which include creating unique science labs and a new fund modelled on the European Research Council to attract researchers after Brexit

The Alphonse Weicker Foundation, powered by BGL BNP Paribas, and the University of Luxembourg’s Interdisciplinary Centre for Security, Reliability and Trust (SnT) have launched a major long-term research and development programme in the field of FinTech (financial technology).

A study led by Warwick University has found a link between the removal of both ovaries during hysterectomy and an increase in heart disease, cancer and premature death.

Mobile phone company Nokia is diversifying into the regulated health sector with the launch of Patient Care, a range of services that will enable doctors and health professionals to remotely monitor their patients with smart devices.

Cancer patients were both willing and capable of self-reporting adverse events and are able to provide more information than clinical investigators, according to a study in JAMA Oncology.

A joint project by the health and digital technologies directorates aims to break the logjam in adopting ICT, promoting greater patient involvement and easing the flow of medical data for research, EU digital chief Roberto Viola tells Healthy Measures

Brexit is clouding its future role in the new common patent, but Benoit Battistelli, head of the European Patent Office thinks there are ways to keep the UK in the system

Mark Ferguson makes no bones about the opportunities, saying “With Brexit, there is more upside than downside for Irish science”

The WHO’s first-ever list of antibiotic-resistant “priority pathogens” names 12 families of bacteria that pose the greatest threat to humans. The list is intended to ensure R&D responds to public health needs

Aix-Marseille University opens call for applications to its DOC2AMU doctoral programme

EU-funded researchers in poorer member states will get higher wages after politicians argued the current remuneration structure fuels an east-to-west brain drain. But it is not clear how much the increase will cost - or how it will be funded

Relaxed rules on massing and analysing data for commercial gain viewed as an opportunity for the UK after it leaves the bloc

Companies working to commercialise the use of Crispr–Cas9 in human therapies are choosing the US over Europe to raise money

As more health data gets stored and analysed, the challenges of governance and culture stand in the way of progress, a Science|Business Healthy Measures conference heard. A solution: citizen involvement